Efficacy/Safety of Low-/High-Dose Perampanel as First Adjunctive Therapy in Patients With Focal-Onset Seizures: Post Hoc Analysis of the FAME Study

被引:0
|
作者
Seo, Dae Won [1 ]
Lee, JiWoong [2 ]
Dash, Amitabh [3 ]
Lee, Sang Kun [4 ]
Lee, Sang-Ahm [5 ]
Malhotra, Manoj [6 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Eisai Korea Inc, Seoul, South Korea
[3] Eisai Singapore Pte Ltd, Singapore, Singapore
[4] Seoul Natl Univ Hosp, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[6] Eisai Inc, Woodcliff Lake, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
201
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [41] Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study
    Lattanzi, Simona
    Ranzato, Federica
    Di Bonaventura, Carlo
    Bonanni, Paolo
    Gambardella, Antonio
    Tartara, Elena
    Assenza, Giovanni
    Procaccini, Michela
    Falsetto, Nathalie
    Villano, Valentina
    Camattari, Gabriele
    Ori, Alessandra
    Di Gennaro, Giancarlo
    NEUROLOGY AND THERAPY, 2024, 13 (04) : 1203 - 1217
  • [42] Long-Term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients (Aged ≥60 Years) with Focal-Onset Seizures (FOS): Post Hoc Analysis of Open-Label Extension (OLEx) Studies by Enzyme-Inducing Anti-Seizure Medication (EIASM) Use
    Marawar, Rohit
    Leppik, Ilo E.
    Wechsler, Robert T.
    Patten, Anna
    Ngo, Leock Y.
    Malhotra, Manoj
    ANNALS OF NEUROLOGY, 2021, 90 : S110 - S111
  • [43] Plasma concentrations/clinical effects of perampanel 4 mg/day monotherapy for focal-onset seizures (FOS): post hoc analysis by body mass index (BMI)
    Leppik, Ilo E.
    Yamamoto, Takamichi
    Ngo, Leock Y.
    Yasuda, Sanae
    Patten, Anna
    Hiramatsu, Hidetaka
    Watanabe, Kazuaki
    Shiba, Sari
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 147 - 148
  • [44] Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed/currently untreated recurrent focal-onset seizures: FREEDOM Study 342 Extension Phase
    Yamamoto, T.
    Lim, S. C.
    Ninomiya, H.
    Kubota, Y.
    Shin, W. C.
    Kim, D. W.
    Shin, D. J.
    Hoshida, T.
    Iida, K.
    Ochiai, T.
    Matsunaga, R.
    Hiramatsu, H.
    Kim, J. H.
    EPILEPSIA, 2022, 63 : 25 - 25
  • [45] Efficacy/safety of perampanel in patients aged 4-<12 years with focal-onset or generalised tonic-clonic seizures who converted to monotherapy
    Fogarasi, Andras
    Ngo, Leock Y.
    Patten, Anna
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 267 - 268
  • [46] Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies
    Steinhoff, Bernhard J.
    Patten, Anna
    Williams, Betsy
    Malhotra, Manoj
    EPILEPSIA, 2020, 61 (02) : 278 - 286
  • [47] Study 512 design: A prospective, observational, multicentre study of perampanel as first adjunctive therapy in routine clinical care of patients aged ≥12 years with focal-onset seizures or generalised tonic-clonic seizures associated with idiopathic generalised epilepsy
    Burd, S.
    Assenza, G.
    Quintas, S.
    Gil Lopez, F. J.
    Wagner, J.
    Patten, A.
    Sainz-Fuertes, R.
    Lagarde, S.
    Sejbaek, T.
    Vlasov, P.
    Kharkovskiy, V.
    Lebedeva, A.
    EPILEPSIA, 2022, 63 : 141 - 141
  • [48] Efficacy of Perampanel (PER) as Adjunctive Therapy in Patients with Focal Epilepsy and Secondarily Generalized Seizures Associated with Brain Tumours (PERADET Study)
    Coppola, A.
    Balestrini, S.
    Nozzolillo, A.
    Troisi, S.
    Sueri, C.
    Belcastro, V.
    Ferlazzo, E.
    EPILEPSIA, 2018, 59 : S173 - S173
  • [49] Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study)
    Yamamoto, Takamichi
    Lim, Sung Chul
    Ninomiya, Hirotomo
    Kubota, Yuichi
    Shin, Won Chul
    Kim, Dong Wook
    Shin, Dong Jin
    Hoshida, Tohru
    Iida, Koji
    Ochiai, Taku
    Matsunaga, Risa
    Higashiyama, Hiroyuki
    Hiramatsu, Hidetaka
    Kim, Ji Hyun
    EPILEPSIA OPEN, 2020, 5 (02) : 274 - 284
  • [50] Efficacy and Safety of Perampanel Monotherapy in Patients Aged ≥12 to &lt;18 Years with Newly Diagnosed/currently Untreated Recurrent Focal-onset Seizures (FOS): FREEDOM Study 342
    Ngo, Leock Y.
    Kim, Ji Hyun
    Lim, Sung Chul
    Yamamoto, Takamichi
    Patten, Anna
    Malhotra, Manoj
    PEDIATRICS, 2022, 149 (01)